Q4 2018 Holdings
Filed 2019-02-14 | 55 holdings | $67.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $26.2M | 4,150,639 | 38.8% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $26.0M | 2,411,623 | 38.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $7.8M | 80,868 | 11.5% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $6.9M | 1,890,507 | 10.3% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $73.0K | 6,687,523 | 0.1% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $67.6K | 4,744,062 | 0.1% |
| Merus N V | COM | N5749R100 | $63.2K | 4,514,913 | 0.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $39.0K | 2,775,156 | 0.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $31.0K | 574,967 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $29.2K | 688,851 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $25.9K | 2,781,346 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $22.4K | 1,769,029 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $21.5K | 593,465 | 0.0% |
| AC Immune SA(ACIU) | SHS | H00263105 | $21.1K | 2,230,027 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $20.6K | 17,426,968 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $19.8K | 7,457,921 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $17.3K | 6,230,418 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $14.4K | 1,150,445 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $14.1K | 220,265 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $13.6K | 3,364,421 | 0.0% |
| Calithera Biosciences Inc(CALAEUR) | COM | 13089P101 | $13.2K | 3,298,282 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $13.0K | 1,215,727 | 0.0% |
| Galmed Pharmaceuticals LTD(GLMD) | SHS | M47238106 | $12.8K | 1,878,508 | 0.0% |
| Verastem Inc | COM | 92337C104 | $11.8K | 3,513,994 | 0.0% |
| Biolinerx LTD | SPONSORED ADS | 09071M106 | $11.4K | 25,995,575 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $11.3K | 1,788,774 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $11.0K | 1,639,458 | 0.0% |
| Spring BK Pharmaceuticals Inc | COM | 849431101 | $9.9K | 951,701 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $9.0K | 899,617 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $8.8K | 1,987,669 | 0.0% |
| VBI Vaccines Inc(VAC2USD) | COM NEW | 91822J103 | $8.3K | 5,216,857 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $7.9K | 2,978,708 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $6.9K | 675,000 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $6.8K | 2,904,684 | 0.0% |
| Immune Design Corp | COM | 45252L103 | $6.7K | 5,185,383 | 0.0% |
| Forward Pharma A/S | SPONSORED ADR | 34986J105 | $6.6K | 8,480,079 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $5.2K | 843,146 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM NEW | 12648L601 | $5.1K | 6,929,690 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $5.0K | 252,693 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $4.9K | 200,500 | 0.0% |
| Erytech Pharma | SPONSORED ADR | 29604W108 | $4.2K | 625,000 | 0.0% |
| Principia Biopharma Inc(PRNB) | COM | 74257L108 | $4.0K | 146,300 | 0.0% |
| Oncomed Pharmaceuticals Inc | COM | 68234X102 | $3.0K | 4,042,989 | 0.0% |
| Contrafect Corp(CFRXEUR) | COM | 212326102 | $2.9K | 1,898,990 | 0.0% |
| Merrimack Pharmaceuticals Inc(MACKEUR) | COM NEW | 590328209 | $2.8K | 721,935 | 0.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $2.4K | 643,059 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $1.9K | 451,850 | 0.0% |
| Vical Inc | COM NEW | 925602203 | $1.5K | 1,285,848 | 0.0% |
| Genocea Biosciences Inc | COM | 372427104 | $1.5K | 5,114,455 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $1.2K | 580,368 | 0.0% |